Titlebook: Novel Developments in Futuristic AI-based Technologies; Manoj Sahni,José M. Merigó,Walayat Hussain Book 2023 The Editor(s) (if applicable)

只看該作者 · 發(fā)表于 2025-3-30 19:24:49

S. R. Singh,R. B. Singh,Akshika Rastogi,Surbhi Singhala concentrations of ET-1 which have been observed in various clinical conditions [3]. However, due to the difficulty arising from the use of such a potent vaso-pressor agent on an experimental basis in humans comparatively few such experiments have been performed in man.

只看該作者 · 發(fā)表于 2025-3-30 22:17:57

Sandra Samuel,R. Maheswari,N. Mohanas. This article reviews current knowledge on the potential role of endogenous ET-1 in myocardial ischemia and infarction, as well as the role of this peptide in acute situations of impaired NO synthesis, especially focusing on recent evidence obtained in our laboratory with the use of specific antagonists of ET-1 receptors.

只看該作者 · 發(fā)表于 2025-3-31 01:30:33

只看該作者 · 發(fā)表于 2025-3-31 08:00:50

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 23:51
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved